Projects per year
Personal profile
Education
- 1991 PhD. State university of new york at buffaloVirology
- 1990 M.S. State university of new york at BuffaloMol Biology
- 1986 M.S. National Taiwan University Institute of Plant Biology
- 1981 B.S. National Taiwan University Plant Biology
Experience
- 2019- Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2018- Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2012- Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2011-Senior Scientist/Consultant, PRI, Albany
- 2011- Board member/consultant Signal Transduction, Inc. Albany
- 2003-2011 Senior Scientist, Ordway Research Institute
- 2002-2010 Research Scientist, VA Medical Center Research
- 1999-2002 Assist professor, Albany Medical College
- 1994-1998 Research Fellow, Albany Medical College
Research Interests
- Biochemical and molecular biological medicine
Awards
- 2016 Excellent publication award at Taipei Medical University
- 2017 Enterprise innovation competition for 4 Universities, 1st place award
- 2017 Enterprise innovation competition Taipei Medical University 1st place award
- 2017 Enterprise innovation competition Ministry of Education Outstanding
- 2018 Outstanding publication award at Taipei Medical University First prize
- 2019 Dr. Ta-Cheng Tung's Basic Cancer Research Award
Related Link
Fingerprint
- 1 Similar Profiles
Network
-
Pathogenic Role of Integrin Αvβ3—Pd-L1—Β-Catenin Axis and Its Therapeutic Strategies in Colorectal Cancer
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Define the Attributes of a Novel Theranostic Nanoparticle Dl-N2 to Targeted Integrin Αvβ3 Network in Cholangiocarcinoma( II )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
標靶整合素αvβ3-FAK訊號網絡的膽管癌診療策略開發-標靶膽管癌整合素αvβ3訊號網絡的新型診療性奈米微脂體DL-N2之研究(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
針對PD-L1表現機制所發展出之口腔癌治療策略(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
針對PD-L1 表現機制所發展出之口腔癌治療策略(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
(Thyroid) Hormonal regulation of breast cancer cells
Hercbergs, A., Lin, H. Y., Mousa, S. A. & Davis, P. J., Jan 2023, In: Frontiers in Endocrinology. 13, 1109555.Research output: Contribution to journal › Short survey › peer-review
Open Access -
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
Chen, Y. F., Lawal, B., Huang, L. J., Kuo, S. C., Sumitra, M. R., Mokgautsi, N., Lin, H. Y. & Huang, H. S., Jan 2023, In: Molecules. 28, 2, 555.Research output: Contribution to journal › Article › peer-review
Open Access -
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside improves female ovarian aging
Lin, H. Y., Yang, Y. N., Chen, Y. F., Huang, T. Y., Crawford, D. R., Chuang, H. Y., Chin, Y. T., Chu, H. R., Li, Z. L., Shih, Y. J., Chen, Y. R., Yang, Y. C. S. H., Ho, Y., Davis, P. J., Whang-Peng, J. & Wang, K., Aug 30 2022, In: Frontiers in Cell and Developmental Biology. 10, 862045.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to “Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic” [Steroids 72 (2) (2007) 180–187, (S0039128X06002509), (10.1016/j.steroids.2006.11.014)]
Lin, H. Y., Tang, H. Y., Shih, A., Keating, T., Cao, G., Davis, P. J. & Davis, F. B., Nov 2022, In: Steroids. 187, 109111.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Extranuclear effects of thyroid hormones and analogs during development: An old mechanism with emerging roles
Incerpi, S., Gionfra, F., De Luca, R., Candelotti, E., De Vito, P., Percario, Z. A., Leone, S., Gnocchi, D., Rossi, M., Caruso, F., Scapin, S., Davis, P. J., Lin, H. Y., Affabris, E. & Pedersen, J. Z., Sept 23 2022, In: Frontiers in Endocrinology. 13, 961744.Research output: Contribution to journal › Review article › peer-review
Open Access1 Citation (Scopus)